Abstracts tagged "Calcinosis and scleroderma"

Abstract Number: 2969 • 2015 ACR/ARHP Annual Meeting
X-Ray Diffraction of Spontaneously Draining Calcinosis in Patients with Scleroderma
Vivien Hsu¹, Thomas Emge² and Naomi Schlesinger³, ¹Medicine, Rutgers University, New Brunswick, NJ, ²Dept of Chemistry and Chemical Biology, Rutgers- the State University, Piscataway, NJ, ³Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ
Background/Purpose: Calcinosis is caused by deposition of calcified materials in the soft tissues (1). Hydroxyapatite (HA) is reported to be its major constituent (2). Mechanical…
Abstract Number: 1686 • 2014 ACR/ARHP Annual Meeting
DUAL Energy Computed Tomography for the Evaluation of Calcinosis in Systemic Sclerosis
Vivien Hsu¹, Mark Bramwit² and Naomi Schlesinger³, ¹Rheumatology, RWJ Med Schl Scleroderma Prog, New Brunswick, NJ, ²Radiology, Robert Wood Johnson University Hospital, New Brunswick, NJ, ³Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ
Background/Purpose: To better characterize the soft tissue details of systemic sclerosis--related (SSc) calcinosis of the hands using dual-energy computer tomography (DECT). DECT is an imaging…
Abstract Number: 684 • 2013 ACR/ARHP Annual Meeting
Clinical Characteristics Of Scleroderma Patients With Calcinosis In a Single-Center Cohort
Danielle Velez¹ and Vivien M. Hsu², ¹RWJMS, South Plainfield, NJ, ²Rheumatology, RWJ Med Schl Scleroderma Prog, New Brunswick, NJ
Clinical characteristics of scleroderma patients with calcinosis in a single-center cohort Background/Purpose: Calcinosis is soft tissue deposition of calcium hydroxyapatite crystals in scleroderma spectrum disorder…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].